Dechra Pharmaceuticals (DPH)

Sector:

Pharma and Biotech

Index:

FTSE 100

3,750.00p
   
  • Change Today:
      18.00p
  • 52 Week High: 5,405.00p
  • 52 Week Low: 3,110.00p
  • Currency: UK Pounds
  • Shares Issued: 108.39m
  • Volume: 187,398
  • Market Cap: £4,064.73m
  • RiskGrade: 121

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17
Continuing Operations          
Revenue 332.40 299.80 248.50 231.40 194.10
Operating Profit/(Loss) 57.40 40.30 23.30 17.00 26.30
Profit Before Tax 53.40 35.40 19.50 9.00 19.00
Profit After Tax 40.70 23.30 13.20 15.50 26.90
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 40.70 23.30 13.20 15.50 26.90
           
Continuing EPS          
Earnings per Share - Basic 37.59p 21.56p 12.85p 15.14p 28.80p
Earnings per Share - Diluted 37.38p 21.44p 12.80p 15.09p 28.69p
Earnings per Share - Adjusted 64.37p 54.60p 43.60p 41.89p 37.72p
Continuing and Discontinued EPS          
Earnings per Share - Basic 37.59p 21.56p 12.85p 15.14p 28.80p
Earnings per Share - Diluted 37.38p 21.44p 12.80p 15.09p 28.69p
Earnings per Share - Adjusted 64.37p 54.60p 43.60p 41.89p 37.72p
Dividend per Share 12.00p 11.11p 10.29p 9.50p 7.33p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17
Total Non-Current Assets 801.70 835.10 727.40 780.90 428.00
Net Current Assets cn/a cn/a cn/a cn/a cn/a
Total Assets 1,177.70 1,205.90 988.30 1,040.30 636.20
Total Liabilities 538.60 580.50 511.40 536.20 320.90
Net Assets 639.10 625.40 476.90 504.10 315.30
           
Shareholders Funds 639.10 625.40 476.90 504.10 313.70
Minority Interests/Other Equity n/a n/a n/a n/a 1.60
Total Equity 639.10 625.40 476.90 504.10 315.30

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page